Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Am J Kidney Dis. 2018 Sep 21;73(1):82–89. doi: 10.1053/j.ajkd.2018.07.009

Figure 1:

Figure 1:

Example eGFR data to demonstrate estimated time to 40% decline using the standard two-point method (Method 1) and our proposed regression method (Method 2). Dashed horizontal lines represent 40% decline thresholds for each method. Hollow triangles represent the two eGFR measurements used for Method 1, whereas all eGFR assessments (hollow and solid) are used for Method 2.